MyFinsight
Home
Blog
About
Property, plant and
equipment, gross
$3,828K
(-35.37%↓ Y/Y)
Intangible assets, net
$5,507K
(175.76%↑ Y/Y)
Property, plant, and
equipment, net
$2,069K
(-33.19%↓ Y/Y)
Claims and advances
$656K
(-3.53%↓ Y/Y)
Inventory
$640K
(-52.56%↓ Y/Y)
Cash and cash
equivalents
$331K
(-27.09%↓ Y/Y)
Deposits and advances
$214K
(0.94%↑ Y/Y)
Accounts receivable, net
$56K
(-35.63%↓ Y/Y)
Current investment
$23K
Less accumulated
depreciation
$1,759K
(-37.76%↓ Y/Y)
Total non-current
assets
$8,232K
(42.18%↑ Y/Y)
Total current assets
$1,264K
(-41.29%↓ Y/Y)
Total assets
$9,496K
(19.55%↑ Y/Y)
Total liabilities and
stockholders equity
$9,496K
(19.55%↑ Y/Y)
Total stockholders
equity
$6,132K
(0.89%↑ Y/Y)
Total liabilities
$3,364K
(80.38%↑ Y/Y)
Accumulated deficit
-$130,228K
(-6.44%↓ Y/Y)
Accumulated other
comprehensive loss
-$5,705K
(-63.05%↓ Y/Y)
Common stock and
additional paid-in...
$142,065K
(7.69%↑ Y/Y)
Total current
liabilities
$3,215K
(86.38%↑ Y/Y)
Total non-current
liabilities
$149K
(6.43%↑ Y/Y)
Accounts payable
$1,618K
(73.42%↑ Y/Y)
Current loans
$933K
Accrued liabilities and
others
$664K
(-16.16%↓ Y/Y)
Non-current loans
$149K
Back
Back
Balance Sheet
IGC Pharma, Inc. (IGC)
IGC Pharma, Inc. (IGC)
source: myfinsight.com